Dow Down 0.17% Nasdaq Down 0.28%

VIVUS Inc. (VVUS)

-NasdaqGS
3.86 Down 0.16(3.98%) 4:00PM EDT
|After Hours : 3.81 Down 0.05 (1.30%) 5:11PM EDT
Prev Close:4.02
Open:4.00
Bid:3.81 x 1700
Ask:4.00 x 3000
1y Target Est:6.00
Beta:1.66
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:3.74 - 4.04
52wk Range:3.32 - 11.64
Volume:2,955,104
Avg Vol (3m):2,100,370
Market Cap:399.36M
P/E (ttm):N/A
EPS (ttm):-1.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for VVUS

Comparison

Symbol% ChgMkt Cap
VVUSDown 3.98%399.36M
LLYDown 0.75%69.50B
GSKDown 0.69%110.42B
PFEDown 0.67%187.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:3.6
PEG Ratio (5 yr expected):-0.89

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback